NFKB1 and asthma: miR-532-3p was shown to inhibit nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) in vitro in response to corticosteroid treatment and was predictive of FEV1 gain on inhaled corticosteroid treatment in children with asthma [42].